Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
AMPK is mitochondrial medicine for neuromuscular...
Journal article

AMPK is mitochondrial medicine for neuromuscular disorders

Abstract

Duchenne muscular dystrophy (DMD), myotonic dystrophy type 1 (DM1), and spinal muscular atrophy (SMA) are the most prevalent neuromuscular disorders (NMDs) in children and adults. Central to a healthy neuromuscular system are the processes that govern mitochondrial turnover and dynamics, which are regulated by AMP-activated protein kinase (AMPK). Here, we survey mitochondrial stresses that are common between, as well as unique to, DMD, DM1, and …

Authors

Mikhail AI; Ng SY; Mattina SR; Ljubicic V

Journal

Trends in Molecular Medicine, Vol. 29, No. 7, pp. 512–529

Publisher

Elsevier

Publication Date

July 2023

DOI

10.1016/j.molmed.2023.03.008

ISSN

1471-4914